|
|---|
Category:License-Fitness for Duty (FFD) Performance Report
MONTHYEARML24058A1582024-02-27027 February 2024
Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2023 Per 10 CFR 26.717(c) & 10 CFR 26.203
ML24054A3662024-02-13013 February 2024
Annual Fatigue Reporting Form for 2023
ML24054A3962024-02-13013 February 2024
Annual Fatigue Reporting Form for 2023
ML24030A6502024-01-30030 January 2024
Single Positive Test Form Collected on 04/24/2023
ML24030A6512024-01-30030 January 2024
Single Positive Test Form Collected on 05/16/2023
ML24030A6492024-01-30030 January 2024
Single Positive Test Form Collected on 04/10/2023
ML24030A6812024-01-30030 January 2024
Single Positive Test Form Collected on 04/25/2023
ML24030A6472024-01-30030 January 2024
Single Positive Test Form Collected on 03/02/2023
ML24030A6462024-01-30030 January 2024
Single Positive Test Form Collected on 02/27/2023
ML24030A6482024-01-30030 January 2024
Single Positive Test Form Collected on 04/10/2023
ML24030A6422024-01-30030 January 2024
Single Positive Test Form Collected on 01/31/2023
ML24030A6552024-01-30030 January 2024
Single Positive Test Form Collected on 11/14/2023
ML24030A6412024-01-30030 January 2024
Single Positive Test Form Collected on 01/31/2023
ML24030A6402024-01-30030 January 2024
Single Positive Test Form Collected on 01/10/2023
ML24030A6542024-01-30030 January 2024
Single Positive Test Form Collected on 08/08/2023
ML24030A6432024-01-30030 January 2024
Single Positive Test Form Collected on 02/07/2023
ML24030A6442024-01-30030 January 2024
Single Positive Test Form Collected on 02/08/2023
ML24030A6452024-01-30030 January 2024
Single Positive Test Form Collected on 02/16/2023
ML24030A6522024-01-30030 January 2024
Single Positive Test Form Collected on 07/26/2023
RS-23-045, Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2022 Per 10 CFR 26.717(c) & 10 CFR 26.2032023-02-28028 February 2023
Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2022 Per 10 CFR 26.717(c) & 10 CFR 26.203
ML23055B2272023-02-24024 February 2023
(50-317, 50-318), Annual Fatigue Form for 2022
ML23044A2972023-02-13013 February 2023
Single Positive Test Form Collected on 06/07/2022
ML23044A2832023-02-13013 February 2023
Single Positive Test Form Collected on 01/27/2022
ML23044A2962023-02-13013 February 2023
Single Positive Test Form Collected on 05/17/2022
ML23044A2932023-02-13013 February 2023
Single Positive Test Form Collected on 02/22/2022
ML23044A2902023-02-13013 February 2023
Single Positive Test Form Collected on 02/03/2022
ML23044A2912023-02-13013 February 2023
Single Positive Test Form Collected on 02/17/2022
ML23044A2922023-02-13013 February 2023
Single Positive Test Form Collected on 05/09/2022
ML23044A3272023-02-13013 February 2023
Annual Report Form for Drug and Alcohol Tests for 2022
ML23044A2822023-02-13013 February 2023
Single Positive Test Form Collected on 01/25/2022
ML23044A2862023-02-13013 February 2023
Single Positive Test Form Collected on 01/25/2022
ML23044A2882023-02-13013 February 2023
Single Positive Test Form Collected on 01/28/2022
ML23044A2892023-02-13013 February 2023
Single Positive Test Form Collected on 1/18/2022
ML23044A2842023-02-13013 February 2023
Single Positive Test Form Collected on 01/25/2022
ML23044A2952023-02-13013 February 2023
Single Positive Test Form Collected on 05/17/2022
ML23044A2942023-02-13013 February 2023
Single Positive Test Form Collected on 04/04/2022
ML23044A2872023-02-13013 February 2023
Single Positive Test Form Collected on 01/27/2022
ML23044A2852023-02-13013 February 2023
Single Positive Test Form Collected on 01/25/2022
ML22096A3292022-04-0606 April 2022
Single Positive Test Form Collected on 02/18/2021
RS-22-029, Constellation, Submittal of Annual Fitness for Duty Performance Data Reports for 20212022-02-25025 February 2022
Constellation, Submittal of Annual Fitness for Duty Performance Data Reports for 2021
ML22056A0552022-02-24024 February 2022
Annual Fatigue Report Report Form for 2021
ML22042B2952022-02-11011 February 2022
Annual Report Form for Drug and Alcohol Tests for 2021
ML22027A5552022-01-27027 January 2022
Single Positive Test Form Collected on 02/22/2021
ML22026A5042022-01-26026 January 2022
Single Positive Test Form Collected on 06/14/2021
ML22026A5092022-01-26026 January 2022
Single Positive Test Form Collected on 02/02/2021
ML22026A5082022-01-26026 January 2022
Single Positive Test Form Collected on 10/04/2021
ML22026A5062022-01-26026 January 2022
Single Positive Test Form Collected on 08/24/2021
ML22026A5072022-01-26026 January 2022
Single Positive Test Form Collected on 09/16/2021
ML22026A5052022-01-26026 January 2022
Single Positive Test Form Collected on 08/19/2021
ML22026A4922022-01-26026 January 2022
Single Positive Test Form Collected on 02/23/2021
2024-02-27
[Table view] |
Text
Larry L. Weckbaugh 1650 Calvert Cliffs Parkway Manager Lusby, Maryland 20657 Nuclear Support Services 410 495-3693 0Constellation Nuclear Calvert Cliffs Nuclear Power Plant A Member of the ConstellationEnergy Group March 13, 2002 U. S. Nuclear Regulatory Commission Washington, DC 20555 ATTENTION: Document Control Desk
SUBJECT:
Calvert Cliffs Nuclear Power Plant Unit Nos. 1 & 2; Docket Nos. 50-317 & 50-318 10 CFR Part 26 Report; Fitness for Duty This letter is to report an unsatisfactory performance testing result that was conducted by Quest Diagnostics Incorporated, Norristown, PA, as required by 10 CFR Part 26, Appendix A, Subpart 2.8(e)(4). One blind performance test urine sample containing amphetamine and methamphetamine was reported as negative on February 16, 2002.
Quest Diagnostics Incorporated was contacted on February 19, 2002, and reported that the specimen tested negative on initial screening. The specimen was re-assayed by the initial test (immunoassay) and was assayed by GC/MS confirmed method, and confirmed positive for amphetamine and methamphetamine. The Corrective Action Report from Quest Diagnostics Incorporated is attached.
The following attachments were gathered in our investigation:
(1) Certificate of Analysis from ElSohly Laboratories, Incorporated dated February 19, 2002, for the amphetamine and methamphetamine Batch A- 1955.
(2) Corrective Action Report from Quest Diagnostics Incorporated, dated February 28, 2002 Questions about this incident can be addressed to Ms. Patricia A. Harrison, FFD Program Administrator, at 410-495-3751.
Document Control Desk March 13, 2002 Page 2 Should you have questions regarding this matter, we will be pleased to discuss them with you.
Very truly yours, LLW/TER/bjd Attachments: As stated cc: (Without Attachments)
R. S. Fleishman, Esquire H. J. Miller, NRC J. E. Silberg, Esquire Resident Inspector, NRC Director, Project Directorate I- 1, NRC R. I. McLean, DNR D. M. Skay, NRC
